Nav: Home

Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer

April 21, 2016

Immunotherapy represents an exciting advance in cancer treatment that harnesses the immune system to seek and destroy cancer cells. The programmed death 1 (PD-1) pathway dampens immune responses to tumor cells, and several clinical trials have shown favorable outcomes by targeting PD-1 or its ligand PD-1L. In this issue of JCI Insight, David Hafler and colleagues at Yale University and Massachusetts Institute of Technology examined PD-1-expressing regulatory T cells in glioblastoma multiforme, an extremely aggressive form of brain cancer. Regulatory T cells normally constrain immune responses and keep other types of T cells from mounting hyper-aggressive responses. Although anti-PD1 therapy is generally thought to promote conventional T cell activity, the Hafler team now reports that PD-1 expression on regulatory T cells from the tumors of glioblastoma multiforme patients correlates with regulatory T cell dysfunction. They also found that glioblastoma multiforme patients treated with a PD-1 blocking antibody had a higher proportion of dysfunctional regulatory T cells. These observations suggest the possibility that PD-1 targeting therapies could work, in part, by driving further regulatory T cell dysfunction. Future studies will be needed to more fully understand the contribution of this pathway to anti-tumor effects.
-end-
TITLE: PD-1 marks dysfunctional regulatory T cells in malignant gliomas

AUTHOR CONTACT: David Hafler
Yale School of Medicine
Email: david.hafler@yale.edu

View this article at:http://insight.jci.org/articles/view/85935

JCI Insight is the newest publication from the American Society of Clinical Investigation, a nonprofit honor organization of physician-scientists. JCI Insight is dedicated to publishing a range of translational biomedical research with an emphasis on rigorous experimental methods and data reporting. All articles published in JCI Insight are freely available at the time of publication. For more information about JCI Insight and all of the latest articles go to http://www.insight.jci.org.

JCI Journals

Related Brain Cancer Articles:

A unique amino acid for brain cancer therapy
Researchers discover potential application of amino acid taurine in photodynamic therapy for brain cancer.
Five years before brain cancer diagnosis, changes detectable in blood
Changes in immune activity appear to signal a growing brain tumor five years before symptoms arise, new research has found.
New insight into life-threatening childhood brain cancer
The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.
New potential treatment for aggressive brain cancer in children
Findings present an opportunity for a precision medicine approach to brain tumor treatment.
Encouraging results for patients with aggressive brain cancer
Patients diagnosed with a glioblastoma, and who undergo current standard treatment, have a median survival of 16 months.
Gene identified that drives deadly brain cancer
Scientists have identified a gene that is overactive in a deadly form of brain cancer known as glioblastoma, according to a study at Washington University School of Medicine in St.
Researchers find new biomarker for brain cancer prognosis
Researchers at UT Southwestern Medical Center have found a new biomarker for glioma, a common type of brain cancer, that can help doctors determine how aggressive a cancer is and that could eventually help determine the best course of treatment.
Study reveals new information on how brain cancer spreads
Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
Promise of better targeted treatments now possible in children's brain cancer
More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer.

Related Brain Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".